Company Description
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada.
The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing.
It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.
The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance.
In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders.
Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.
The company was founded in 1980 and is headquartered in Carlsbad, California.
| Country | United States |
| Founded | 1980 |
| IPO Date | Mar 13, 1987 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 317 |
| CEO | Mark A. LeDoux J.D. |
Contact Details
Address: 1535 Faraday Avenue Carlsbad, California 92008-7319 United States | |
| Phone | (760) 736-7700 |
| Website | nai-online.com |
Stock Details
| Ticker Symbol | NAII |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000787253 |
| CUSIP Number | 638842302 |
| ISIN Number | US6388423021 |
| Employer ID | 84-1007839 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Mark A. LeDoux J.D. | Chairman of the Board and Chief Executive Officer |
| Kenneth E. Wolf | President, Chief Operating Officer and Secretary |
| Michael E. Fortin | Chief Financial Officer |
| Shane Conti | Vice President of Global Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 14, 2024 | 10-Q | Quarterly Report |
| Feb 13, 2024 | 10-Q | Quarterly Report |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Dec 12, 2023 | 8-K | Current Report |
| Nov 9, 2023 | 10-Q | Quarterly Report |
| Oct 26, 2023 | DEF 14A | Other definitive proxy statements |
| Sep 21, 2023 | 10-K | Annual Report |
| Aug 16, 2023 | 8-K | Current Report |